Mirvetuximab soravtansine improved overall survival over chemotherapy in patients with FRα-positive, platinum-resistant ovarian cancer.
Paleobiology Professor Kenshu Shimada is leading a study alongside 28 experts. A new scientific study offers significant ...
The Belgian government and French utility Engie have closed the agreement covering the extension of the operation of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback